• N Fakhry, P Schultz, S Morinière, I Breuskin, A Bozec, S Vergez, L de Garbory, D Hartl, S Temam, E Lescanne, V Couloigner, B Barry, French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL), and French Society of Head and Neck Carcinology (SFCCF).
• Department of otorhinolaryngology, head and neck surgery, centre hospitalier universitaire (CHU) la Conception, Aix Marseille université, Assistance publique-Hôpitaux de Marseille, Marseille, France. Electronic address: nicolas.fakhry@ap-hm.fr.
• Eur Ann Otorhinolaryngol Head Neck Dis. 2020 May 1; 137 (3): 159-160.

AbstractIn the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched).Copyright © 2020 Elsevier Masson SAS. All rights reserved.

36 keywords...

hide…